market Inner Banner
  • BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ticker-arrow
    • ({{d.PerChg}}%)
Market | Equity | Daily Market Tracker | IPO Synopsis
IPO SYNOPSIS
Sai Parenteral's Ltd
Registered Office:
No.39 5th Flr Lavanya Arcade-,Jayabheri Enclave Gachibowli,
Rangareddy - 500032,
Telangana, India.
Initial public offer of 10,428,288 equity shares of face value of (Rs) 5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of (Rs) 392 per equity share (Including a Share Premium of (Rs) 387 Per Equity Share) ("Offer Price") aggregating to (Rs) 408.79 Crore comprising a fresh issue of 7,270,408 equity shares of face value of (Rs) 5 each aggregating to (Rs) 285 Crore by the company ("Fresh Issue") and an offer for sale of 3,157,880 equity shares of face value of (Rs) 5 each aggregating to (Rs) 123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute 23.60% of the post-offer paid up equity share capital of the company. Price Band: (Rs) 392 per equity share of face value of (Rs) 5 each. The floor price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of (Rs) 5 each and in multiples of 38 equity shares of face value of (Rs) 5 each thereafter.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
24-Mar-26
27-Mar-26
392.00-0.00
0.00-0.00
Minimum Application for shares in Nos : 38     Further Multiples of : 38
 
(Rs.Cr)
Lead Managers to the Issue
Project Cost
256.50
Arihant Capital Markets Limited
Project Financed
408.79
 
Post Issue
22.09
 
Issue Price
392.00
 
Projects
Capacity expansion and upgradation of manufacturing facilities
Establishment of a new R&D Centre
Repayment / prepayment of certain outstanding borrowings
Working capital requirements
Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)
General corporate purposes
Promoted By
Anil Kumar Karusala
Vijitha Gorrepati
Karusala Aruna
Listing At
BSE
NSE
Registrar to the Issue
No Data Available!!!
.
Stock Broker Name Registration Number Registered Address Branch Address Contact Number Email id
DB (International) Stock Brokers Limited INZ000179035 (BROKING)

IN-DP-CDSL-266-2004 (DEPOSITORY)
Unit No. 210/211/211A at 2nd floor, Dalal Street Commercial Cooperative Society Ltd, Block No.53, Zone 5, Gift City, Gandhinagar, Gujarat-382355 Head Office – 114, New Delhi House, 27 Barakhamba Road, Delhi 110001 011-43606162 compliance@dbonline.in
51, Mini Market T/F Mandir Wali Gali, Yusaf Sarai, New Delhi 110016 011-35936102 greenpark@dbonline.in
C-12, DB Plaza, RDC Raj Nagar, Ghaziabad 201002 0120-4150393 ghaziabad@dbonline.in
Plot No 4, Wasme House, Film City Sector 16A, Noida – 201301 0120-4823200 compliance@dbonline.in
Out Side Jassusar Gate, Bikaner, Rajasthan – 334001 9001643408 bikaner@dbonline.in
Office No 101, City Center, Opp. High Court, M G Road, Indore 452001 9424083019 brajeshsadani@dbonline.in
203, Marshal House 25, Strand Road, Kolkata 700001 033-40055270 b032@dbonline.in
Shop No.-7, 2nd Floor, Amar Complex, Opp. Hanumaan Mandir, The Mall, Solan- 173212 6230604596 parwanoo@dbonline.in
Daga Commodities Private Limited INZ000028833 114, New Delhi House, 27 Barakhamba Road, Delhi 110001- 0120-4823200 compliance@dbonline.in
Daga Business (International) Stock Brokers (IFSC) Private Limited INZ000202436 Unit No. 228, Signature Building, Second Floor, Block 13B, Zone-1, Gift SEZ, Gandhinagar, Gujarat 382355 - 0120-4823200 compliance@dbonline.in

Disclosure regarding proprietary trading:

As required under Circular No. SEBI/MRD/SE/Cir-42/2003 dated 19.11.2003 issued by the Securities and Exchange Board of India; We hereby disclose that in addition to client based business, We are also doing proprietary trading.

Investor Grievances Email ID: investorgrievance@dbonline.in


Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries | Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. | Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors"